Strategic Investments

Through our continued Strategic Investments, we are building a portfolio of promising clinical and pre-clinical stage drug candidates. We believe they will improve people’s lives by creating access to innovative medicine across some of our key therapeutic areas including oncology and respiratory.

Karolinska Development

invoX is the investor and key shareholder of Karolinska Development, which invests in Nordic companies, developing potentially ground-breaking treatments to relieve or cure serious diseases.

More info

Please get in touch, it would be great to hear from you!